Seeking Alpha

Aegerion discloses DoJ subpoena, announces preliminary 2013 sales, 2014 outlook

  • Aegerion (AEGR) shares plunge 10.6% AH after the company couches a disclosure that it has received a subpoena from the DoJ requesting documents regarding its marketing/sales of JUXTAPID in a preliminary sales results PR.
  • The company announces preliminary 2013 sales of $48M-$49M vs. consensus of $49.8M.
  • The company sees sales of $190M-$210M in 2014 vs. consensus of $204.2M with opex of $185M-$195M. Aegerion expects to be cash flow positive by 2H 2014.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: